Search Orphan Drug Designations and Approvals
-
Generic Name: | afatinib |
---|---|
Date Designated: | 07/09/2019 |
Orphan Designation: | Treatment of pancreatic cancer |
Orphan Designation Status: | Designated/Withdrawn |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road P. O. Box 368 Ridgefield, Connecticut 06877 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-